Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATORVASTATIN CALCIUM USP, with a corresponding US DMF Number 33905.
Remarkably, this DMF maintains an Active status since its submission on June 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 02, 2023, and payment made on December 15, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II